Tiansheng Pharmaceutical Group Co.Ltd(002872) (SZ Tiansheng Pharmaceutical Group Co.Ltd(002872) , closing price: 5.25 yuan) released the first quarter performance announcement on April 26, saying that the revenue in the first quarter of 2022 was about 135 million yuan, a year-on-year decrease of 59.48%; The net profit loss is about 15.76 million yuan; The loss of basic earnings per share was 0.0495 yuan.
From January to June 2021, Tiansheng Pharmaceutical Group Co.Ltd(002872) the composition of operating revenue is: pharmaceutical circulation accounts for 53.51% and pharmaceutical manufacturing accounts for 45.05%.
Tiansheng Pharmaceutical Group Co.Ltd(002872) ‘s chairman and general manager are Liu Shuang, male, 29 years old, with a bachelor’s degree.
